Nanosonics
Sydney, AustraliaWebsite
An infection prevention company specializing in the design and manufacture of ultrasound probe decontamination technology.
1open role
Loading company information...
An infection prevention company specializing in the design and manufacture of ultrasound probe decontamination technology.
Company context
Nanosonics prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
Nanosonics Limited is a leading Australian healthcare technology company dedicated to the advancement of infection prevention. Founded in 2001 and headquartered in Sydney, the company has established itself as a global innovator in the medical device sector, particularly through its proprietary automated high-level disinfection technologies. Nanosonics is best known for its flagship Trophon platform, which utilizes a unique sonicated mist of hydrogen peroxide to disinfect ultrasound probes, effectively setting a global standard for patient safety and infection control in clinical settings.
Nanosonics aims to improve the safety of patients, clinics, staff, and the environment by transforming how infection prevention is understood and conducted, and by introducing innovative technologies that deliver improved standards of care.
Founded
2001
Headquarters
Sydney, Australia
Employees
500-1000
Industry
Medtech / Infection Prevention
Strong focus on meaningful work that directly impacts patient safety and infection reduction.
High level of innovation and proprietary technology development.
Regulatory hurdles and long lead times for new product approvals can impact project timelines.
Revenue
AUD 150M - 200M
Funding
Publicly Traded (ASX: NAN)
CEO
Michael Kavanagh
High pressure to maintain compliance and quality standards in a strictly regulated industry.